Ceva re-enforces expertise in freeze-drying with completion of € 2.8m plant >
Ceva Santé Animale intends to use the new freeze-drying facility to increase its toll-manufacturing activity.
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Ceva launches latest of its Vector Vaccines at VIV Asia 2011 >
VECTORMUNE HVT- NDV® generates strong interest at symposium organised to present new strategies to combat Newcastle Disease.
Ceva becomes official partner of Vet2011 >
2011 is World Veterinary year, let’s show pride in our profession “Vet for health, Vet for food, Vet for the planet!”.
Stamp Out Sleeping sickness (S.O.S.) initiative highlighted at WHO 3rd International Conference on Neglected Zoonotic >
At the WHO Third International Conference on Neglected Zoonotic Diseases held on November 23/24 2010, Dr. Anthony Mbonye, the Commissioner of Health Services in Uganda praised the SOS initiative as an excellent example of an “One Health” approach, where experts from the animal, human and public health sectors have worked together to control trypanosomiasis or sleeping sickness.
Ceva vector vaccine symposium now available as a web-seminar >
The highly successful vector vaccines symposium organized by Ceva this October in San Diego can now be viewed online.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?
Ceva adopts new logo >
Following the success of its first 10 year plan, Ceva sets out its vision to create value beyond animal health.
Vector vaccines symposium - 23th September 2010 >
CEVA will hold its first vector vaccines symposium in San Diego, USA from october 6-8th2010. Together with presenting its advanced technology, the forum will encourage the sharing of worldwide experiences
USA: Ceva acquires Summit VetPharm, LLC - 26th August 2010 >
LENEXA, Kan.— Ceva, a global veterinary pharmaceutical group, is pleased to announce the company has entered into an agreement with Sumitomo Corporation of America, and Sumitomo Corporation, to acquire a majority share of Sumitomo’s animal health subsidiary, Summit VetPharm, LLC. Sumitomo Corporation will remain a minority shareholder in the new North American CEVA companion animal business, which...